Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Health Care Winner

Alexion Pharmaceuticals ( ALXN) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 1.2%. By the end of trading, Alexion Pharmaceuticals rose $3.62 (3.9%) to $95.86 on average volume. Throughout the day, 2,068,528 shares of Alexion Pharmaceuticals exchanged hands as compared to its average daily volume of 1,546,400 shares. The stock ranged in a price between $93.34-$99.04 after having opened the day at $93.73 as compared to the previous trading day's close of $92.24. Other companies within the Health Care sector that increased today were: Onyx Pharmaceuticals ( ONXX), up 51.3%, Bacterin International Holdings ( BONE), up 20.0%, Spherix ( SPEX), up 19.3% and Prima Biomed ( PBMD), up 18.9%.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of life-transforming therapeutic products. Alexion Pharmaceuticals has a market cap of $18.3 billion and is part of the drugs industry. The company has a P/E ratio of 64.2, above the S&P 500 P/E ratio of 17.7. Shares are down 1.6% year to date as of the close of trading on Friday. Currently there are 16 analysts that rate Alexion Pharmaceuticals a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Alexion Pharmaceuticals as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front, Pingtan Marine Enterprise ( PME), down 61.1%, Mast Therapeutics ( MSTX), down 38.6%, Insmed ( INSM), down 18.7% and TherapeuticsMD ( TXMD), down 13.5% , were all laggards within the health care sector with Warner Chilcott ( WCRX) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Global Stocks Retreat as U.S.-China Trade War Intensifies

Global Stocks Retreat as U.S.-China Trade War Intensifies

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods